Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals higher admission red blood cell distribution width increases in-hospital mortality in heart failure, indicating utility for ICU risk stratification.
Red blood cell distribution width (RDW) has been found to be associated with developing cardiovascular events. However, clinical evidence concerning its level on admission and hospitalized mortality are relatively rare among patients with heart failure (HF). We explored whether the RDW indicator on admission was related to the risk of in-hospital mortality among HF patients. We conducted a retrospective analysis on a dataset from the MIMIC-IV database where a total of 15,983 participants with chronic HF was stored. The association between the RDW value on admission and in-hospital mortality risk was assessed. The in-hospital mortality rate was 1988 (12.4%). Our smooth curve analysis supported that admission RDW value had an approximate linear correlation with in-hospital mortality risk. Then, we also found that the RDW was independently associated with a higher in-hospital mortality risk [1.1 (1.1, 1.2) < 0.001]. A ROC analysis suggested that the RDW had a higher AUC of 0.6246 with a sensitivity (58.25%) and specificity (59.86%) than red blood cell-related indicators, indicating a better diagnosability on detecting in-hospital mortality risk. Furthermore, the folding point K for identified saturation threshold of RDW was at 20.2%. Our results showed that RDW was still significantly associated with a higher in-hospital mortality risk [1.1 (1.1, 1.2) < 0.001] when the RDW value was less than 20.2%. The independent association was disappeared gradually with an increased RDW value > 20.2%. Elevated RDW levels on admission were obviously associated with a higher in-hospital mortality risk among these HF patients. This might further provide a strong support for RDW as a risk-stratification factor for HF prognosis. However, individual diagnostic power of RDW is modest, and it may be more useful in combination with other validated markers of mortality in HF such as BNP. Further predictive studies needs to confirm our findings.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: